Suppr超能文献

药物研发中开源软件的情况。

The case for open-source software in drug discovery.

作者信息

DeLano Warren L

机构信息

DeLano Scientific LLC, 400 Oyster Point Blvd., Suite 213, San Francisco, CA 94080, USA.

出版信息

Drug Discov Today. 2005 Feb 1;10(3):213-7. doi: 10.1016/S1359-6446(04)03363-X.

Abstract

Widespread adoption of open-source software for network infrastructure, web servers, code development, and operating systems leads one to ask how far it can go. Will "open source" spread broadly, or will it be restricted to niches frequented by hopeful hobbyists and midnight hackers? Here we identify reasons for the success of open-source software and predict how consumers in drug discovery will benefit from new open-source products that address their needs with increased flexibility and in ways complementary to proprietary options.

摘要

开源软件在网络基础设施、网络服务器、代码开发和操作系统方面的广泛采用,让人不禁要问它能走多远。“开源”会广泛传播,还是会局限于满怀希望的业余爱好者和深夜黑客常涉足的小众领域?在此,我们找出开源软件成功的原因,并预测药物研发领域的消费者将如何从新的开源产品中受益,这些产品能以更高的灵活性并以补充专有选项的方式满足他们的需求。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验